Abstract | BACKGROUND: RESULTS: Our findings show that MED could significantly inhibit ox-LDL-induced macrophage foam cell formation and suppress the expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), which is a receptor for ox-LDL. Additionally, MED could significantly inhibit the secretion of proinflammatory cytokines, such as tumor necrosis factor (TNF-α), interleukin (IL)-6, and IL-1β. Mechanistically, MED inhibited NF-κB activation by blocking IκB-α degradation and reducing NF-κB DNA binding activity. Moreover, MED dramatically reduced the occurrence of HFD-induced atherosclerotic lesions in ApoE (-/-) mice. CONCLUSIONS: Our study shows that MED can inhibit macrophage foam cell formation and activation by inhibiting NF-κB activation, thereby protecting ApoE (-/-) mice from HFD-induced atherosclerosis. Our findings suggest that MED might be a potential lead compound for the development of antiatherosclerotic therapeutics.
|
Authors | Xiaochun Xia, Yang Li, Qiang Su, Zhengrong Huang, Yuemao Shen, Weihua Li, Chundong Yu |
Journal | Cell & bioscience
(Cell Biosci)
Vol. 5
Pg. 23
( 2015)
ISSN: 2045-3701 [Print] England |
PMID | 26045945
(Publication Type: Journal Article)
|